Published in

Springer, Neurological Sciences, 11(43), p. 6271-6278, 2022

DOI: 10.1007/s10072-022-06276-5

Links

Tools

Export citation

Search in Google Scholar

Interleukin-31 and soluble CD40L: new candidate serum biomarkers that predict therapeutic response in multiple sclerosis

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO